#United States #New York #Gross Law Firm #TMCI #Treace Medical Concepts

Legal Notice to Treace Medical Concepts Shareholders

In an important notification for investors, The Gross Law Firm has advised shareholders of Treace Medical Concepts, Inc. (NASDAQ: TMCI) to reach out before June 10, 2025. This notice is aimed at those who purchased shares during a significant period reflecting potential legal claims due to alleged misleading information issued by the company.

Background of Treace Medical Concepts

Treace Medical Concepts has garnered attention in the medical device sector, especially for its innovative 3D bunion correction system known as Lapiplasty. However, recent claims indicate that the company might not have been forthcoming regarding competitive pressures affecting product demand. This raises critical concerns about the financial wellbeing of investors who purchased shares amid these circumstances.

Allegations Against Treace Medical Concepts

According to the class action notice, during the class period from May 8, 2023, to May 7, 2024, Treace Medical allegedly issued statements that were materially false or misleading. The central issues highlighted in the claims are:
1. Failure to Disclose Competition Impact: The company reportedly downplayed how competition adversely affected the sales and usage of the Lapiplasty product.
2. Declining Revenue: As a result of declining consumer interest and sales, Treace Medical needed to hasten plans for introducing alternative products that could replace traditional surgical methods.
3. Misleading Public Statements: Positive assertions made by the company about its business outlook and operations lacked factual support, leading to misrepresentations that inflated stock values.

Enrollment and Class Action Registration

Investors who hold shares of Treace Medical must not hesitate to register for this class action. By doing so, they will gain access to a portfolio monitoring service that provides ongoing updates about the lawsuit. The established deadline for individuals to seek lead plaintiff status is June 10, 2025. Importantly, no fees will be incurred by those participating in the class action.

This proactive step is crucial for any shareholder looking to expedite justice and potentially recover losses incurred during the mentioned period. For those interested in learning more or taking the next steps, The Gross Law Firm provides a convenient registration link:

Register Here

Why Choose The Gross Law Firm?

The Gross Law Firm is recognized nationwide for its commitment to investor protection. Their mission centers on holding corporations accountable for dishonest practices. By ensuring that companies operate within ethical frameworks, The Gross Law Firm aims to recover losses for investors attributed to misleading statements and practices. As part of their comprehensive approach, they emphasize good corporate citizenship as essential.

Shareholders are encouraged to seize this opportunity to protect their interests and engage with the Gross Law Firm for expert legal counsel. For any inquiries, the firm can be reached via:

• - Phone: (646) 453-8903
• - Email: [email protected]
• - Address: 15 West 38th Street, 12th floor, New York, NY 10018

The deadline is fast approaching, so investors should act promptly to ensure their rights are secured.